Market Overview

UPDATE: Citigroup Initiates Warner Chilcott PLC with Neutral on Pending Activities Execution

Related WCRX
Actavis, Warner Chilcott Receive FTC Clearance for Actavis' Proposed Acquisition of Warner Chilcott
Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Profit Margin

In a report published Friday, Citigroup analyst Liav Abraham initiated coverage on Warner Chilcott PLC (NASDAQ: WCRX) with a Neutral rating and $14.50 price target.

In the report, Abraham noted, “While we acknowledge that the valuation of WCRX is materially lower than that of its peer group, at a 2014e earnings multiple of 4x vs. the sector average of 14x, we forecast a negative 5-year overall revenue CAGR of -5% vs. the peer group average of +7%. We prefer to remain on the sidelines pending execution on business development activities that could contribute to the company's longer term growth profile.”

Warner Chilcott PLC closed on Thursday at $13.51.

Latest Ratings for WCRX

Jul 2013Leerink SwannUpgradesMarket PerformOutperform
Jun 2013JefferiesDowngradesBuyHold
May 2013Leerink SwannDowngradesOutperformMarket Perform

View More Analyst Ratings for WCRX
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Initiation Analyst Ratings


Related Articles (WCRX)

View Comments and Join the Discussion!

Partner Center